Organogenesis Holdings Inc (ORGO)

Jun 15, 2026, 11:00 AM EDT - 19 days ago

Organogenesis Holdings Transcript: AGM 2026

2026-05-28T10:17:18.000Z - 5 weeks ago

Organogenesis initiated with a Hold at Truist

2026-05-08T11:17:55.000Z - 2 months ago

Organogenesis downgraded to Neutral from Buy at BTIG

May 7, 2026, 5:00 PM EDT - 2 months ago

Organogenesis Holdings Earnings Call Transcript: Q1 2026

May 7, 2026, 5:00 PM EDT - 2 months ago

Organogenesis Holdings Earnings release: Q1 2026

May 7, 2026, 5:00 PM EDT - 2 months ago

Organogenesis Holdings Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 2 months ago

Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Organogenesis Holdings Proxy statement: Proxy filing

2026-04-28T22:00:57.000Z - 2 months ago

Organogenesis completes rolling submission of ReNu BLA

Apr 28, 2026, 4:30 PM EDT - 2 months ago

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®

2026-04-07T12:03:59.000Z - 3 months ago

Why is Organogenesis Stock (ORGO) Up 20% Today?

2026-04-06T23:05:09.000Z - 3 months ago

Organogenesis achieves primary endpoint in PuraPly study

Apr 6, 2026, 7:02 PM EDT - 3 months ago

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

2026-04-06T21:35:17.000Z - 3 months ago

Organogenesis announces successful FDA meeting, plans to file BLA for ReNu

Apr 6, 2026, 5:30 PM EDT - 3 months ago

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Apr 6, 2026, 7:30 AM EDT - 3 months ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

2026-02-27T12:39:51.000Z - 4 months ago

Organogenesis price target lowered to $8 from $9 at BTIG

Feb 26, 2026, 5:00 PM EST - 4 months ago

Organogenesis Holdings Earnings Call Transcript: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Organogenesis Holdings Earnings release: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Organogenesis Holdings Annual report: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Organogenesis Holdings Annual report: Q4 2025

Feb 26, 2026, 4:05 PM EST - 4 months ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue

Feb 19, 2026, 4:05 PM EST - 4 months ago

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

2025-12-23T21:10:37.000Z - 6 months ago

Organogenesis initiates rolling submission of BLA to FDA for ReNu

Dec 23, 2025, 4:05 PM EST - 6 months ago

Organogenesis Announces Initiation of Biologics License Application for ReNu®

2025-12-15T21:30:39.000Z - 7 months ago

Organogenesis plans to file BLA for ReNu before end of December

2025-11-20T12:16:47.000Z - 8 months ago

Organogenesis price target raised to $9 from $7 at BTIG

Nov 6, 2025, 5:00 PM EST - 8 months ago

Organogenesis Holdings Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

Organogenesis Holdings Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

Organogenesis Holdings Earnings release: Q3 2025

Nov 6, 2025, 4:05 PM EST - 8 months ago

Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance

Nov 3, 2025, 1:10 PM EST - 8 months ago

Organogenesis Applauds CMS's Significant Step In Payment Reform

Oct 31, 2025, 4:05 PM EDT - 8 months ago

Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 17, 2025, 2:20 PM EDT - 9 months ago

Organogenesis Holdings Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ORGO

Oct 1, 2025, 4:05 PM EDT - 9 months ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

2025-09-25T20:55:11.000Z - 10 months ago

Organogenesis provides update on second Phase 3 ReNu study

Sep 25, 2025, 4:50 PM EDT - 10 months ago

Organogenesis Provides Update on Second Phase 3 ReNu® Study

Sep 3, 2025, 2:10 PM EDT - 10 months ago

Organogenesis Holdings Transcript: Cantor Global Healthcare Conference 2025

Aug 27, 2025, 4:05 PM EDT - 11 months ago

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Organogenesis Holdings Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Organogenesis Holdings Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Organogenesis Holdings Earnings release: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 11 months ago

Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results

Jul 22, 2025, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

Jul 15, 2025, 9:00 AM EDT - 1 year ago

Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation

May 12, 2025, 8:00 AM EDT - 1 year ago

Organogenesis Holdings Proxy statement: Proxy Filing

May 8, 2025, 5:00 PM EDT - 1 year ago

Organogenesis Holdings Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Organogenesis Holdings Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Organogenesis Holdings Earnings release: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Organogenesis Holdings Proxy statement: Proxy Filing

Apr 11, 2025, 4:05 PM EDT - 1 year ago

Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

Apr 7, 2025, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Feb 27, 2025, 5:00 PM EST - 1 year ago

Organogenesis Holdings Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

Organogenesis Holdings Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

Organogenesis Holdings Earnings release: Q4 2024

Feb 27, 2025, 4:05 PM EST - 1 year ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results

Jan 27, 2025, 7:30 AM EST - 1 year ago

Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025

Dec 19, 2024, 7:00 AM EST - 1 year ago

Organogenesis Holdings Registration statement: Registration Filing

Nov 22, 2024, 4:05 PM EST - 1 year ago

Organogenesis Expands Manufacturing Capacity to Support Future Growth

Nov 15, 2024, 9:25 AM EST - 1 year ago

Organogenesis Commends Final LCDs

Nov 12, 2024, 5:00 PM EST - 1 year ago

Organogenesis Holdings Earnings Call Transcript: Q3 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

Organogenesis Holdings Quarterly report: Q3 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

Organogenesis Holdings Earnings release: Q3 2024

Nov 12, 2024, 4:01 PM EST - 1 year ago

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

Nov 11, 2024, 5:05 PM EST - 1 year ago

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

Oct 16, 2024, 7:30 AM EDT - 1 year ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024

Oct 1, 2024, 4:05 PM EDT - 1 year ago

Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers

Sep 18, 2024, 1:20 PM EDT - 1 year ago

Organogenesis Holdings Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Aug 8, 2024, 5:00 PM EDT - 2 years ago

Organogenesis Holdings Earnings Call Transcript: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 2 years ago

Organogenesis Holdings Quarterly report: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 2 years ago

Organogenesis Holdings Earnings release: Q2 2024

Aug 8, 2024, 4:04 PM EDT - 2 years ago

Organogenesis Shares ReNu® Program Update

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Organogenesis Holdings Registration statement: Registration Filing

Jul 15, 2024, 4:05 PM EDT - 2 years ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Jun 6, 2024, 4:05 PM EDT - 2 years ago

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

May 9, 2024, 5:00 PM EDT - 2 years ago

Organogenesis Holdings Earnings Call Transcript: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Organogenesis Holdings Quarterly report: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Organogenesis Holdings Earnings release: Q1 2024

May 2, 2024, 7:00 AM EDT - 2 years ago

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Organogenesis Holdings Proxy statement: Proxy Filing

Apr 16, 2024, 7:30 AM EDT - 2 years ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Feb 29, 2024, 5:00 PM EST - 2 years ago

Organogenesis Holdings Earnings Call Transcript: Q4 2023

Feb 29, 2024, 5:00 PM EST - 2 years ago

Organogenesis Holdings Annual report: Q4 2023

Feb 29, 2024, 5:00 PM EST - 2 years ago

Organogenesis Holdings Earnings release: Q4 2023

Feb 29, 2024, 4:05 PM EST - 2 years ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

Feb 12, 2024, 7:30 AM EST - 2 years ago

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Feb 8, 2024, 4:05 PM EST - 2 years ago

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

Nov 9, 2023, 5:00 PM EST - 2 years ago

Organogenesis Holdings Earnings Call Transcript: Q3 2023

Nov 9, 2023, 5:00 PM EST - 2 years ago

Organogenesis Holdings Quarterly report: Q3 2023

Nov 9, 2023, 5:00 PM EST - 2 years ago

Organogenesis Holdings Earnings release: Q3 2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

Oct 5, 2023, 7:30 AM EDT - 2 years ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Sep 28, 2023, 9:15 AM EDT - 3 years ago

Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS

Sep 11, 2023, 8:00 AM EDT - 3 years ago

Organogenesis Holdings Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Sep 6, 2023, 4:05 PM EDT - 3 years ago

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Aug 9, 2023, 5:00 PM EDT - 3 years ago

Organogenesis Holdings Earnings Call Transcript: Q2 2023

Aug 9, 2023, 5:00 PM EDT - 3 years ago

Organogenesis Holdings Quarterly report: Q2 2023

Aug 9, 2023, 5:00 PM EDT - 3 years ago

Organogenesis Holdings Earnings release: Q2 2023

Aug 9, 2023, 4:05 PM EDT - 3 years ago

Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance

Jul 10, 2023, 7:30 AM EDT - 3 years ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023

May 21, 2023, 8:20 AM EDT - 3 years ago

TipRanks reveals the top 10 health care sector analysts of the past decade

CABA CYH EXAS MRNA NVAX PFE RARE

May 10, 2023, 5:00 PM EDT - 3 years ago

Organogenesis Holdings Earnings Call Transcript: Q1 2023

May 10, 2023, 5:00 PM EDT - 3 years ago

Organogenesis Holdings Quarterly report: Q1 2023

May 10, 2023, 5:00 PM EDT - 3 years ago

Organogenesis Holdings Earnings release: Q1 2023

May 10, 2023, 4:05 PM EDT - 3 years ago

Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results

May 1, 2023, 8:00 AM EDT - 3 years ago

Organogenesis Holdings Proxy statement: Proxy Filing

Apr 27, 2023, 7:30 AM EDT - 3 years ago

Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors